LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

NCT ID: NCT02091011

Last Updated: 2022-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-27

Study Completion Date

2021-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is to determine the rate and cause of device replacements at 5 years post-implantation. It will assess the battery and device longevity of the Implantable Cardioverter Defibrillators (ICD) and CRT-D Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices. It will also validate the device survival information given in Boston Scientific's Product Performance Report by comparing the pulse generator (PG) survival probability in the study to that presented in the Product Performance Reports (PPR)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Implantable Cardioverter Defibrillators CRT-D Cardiac Resynchronization Therapy Defibrillator

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort group

Subjects who have been implanted within 30 days with a commercially available Boston Scientific ICD or a CRT-D device

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has been implanted within 30 days with a commercially available Boston Scientific ICD or a CRT-D device according to current guidelines and/or center's current practice
* Subject is willing and capable (or appropriate legal representative is willing and capable) of authorizing access to and use of health information as required by an Institution's Institutional Review Board (IRB), Research Ethics Board (REB) or Ethics Committee (EC)
* Is willing and capable (or appropriate legal representative is willing and capable) of providing authorization/consent for participation in the study.

Exclusion Criteria

* Subject is unable or unwilling to comply with the study protocol requirements
* Subject is under the legal age for signing study consent in accordance with state or national law
* Subject has a life expectancy of less than twelve months
* Women of childbearing potential who are or might be pregnant at the time of study enrollment (method of assessment upon physician's discretion)
* Subject on active heart transplant list
* Subject with any prior pulse generator infection or lead infection which is either systemic or localized
* Subject received a commercially available Boston Scientific ICD or CRT-D device with a battery capacity of 1.5 amp/hour or less
* Subject implanted with Boston Scientific's subcutaneous implantable defibrillator system (s-ICD) or has a lead that is under recall/advisory at the time of enrollment
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Samir Saba, MD, FACC, FHRS

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alabama cardiovascular group

Birmingham, Alabama, United States

Site Status

Birmingham Heart Clinic, P.C.

Birmingham, Alabama, United States

Site Status

Phoenix Heart, PLLC

Glendale, Arizona, United States

Site Status

Pima Heart Physicians PC

Tucson, Arizona, United States

Site Status

Southern Arizona VA Health Care System

Tucson, Arizona, United States

Site Status

Mercy Clinic Cardiology Physician Plaza

Rogers, Arkansas, United States

Site Status

VA Loma Linda Healthcare System

Loma Linda, California, United States

Site Status

Washington Hospital Center

Washington D.C., District of Columbia, United States

Site Status

Bradenton Cardiology Center

Bradenton, Florida, United States

Site Status

Jackson Memorial Hospital, JHS Office of Research

Miami, Florida, United States

Site Status

Florida Electrophysiology, LLC

Orlando, Florida, United States

Site Status

Bay Area Heart Center

St. Petersburg, Florida, United States

Site Status

Alexian Brothers

Elk Grove Village, Illinois, United States

Site Status

Franciscan Physician Network Cardiology Crown Point

Crown Point, Indiana, United States

Site Status

The Heart Group, PC

Newburgh, Indiana, United States

Site Status

InityPoint Health - St. Luke's Hospital

Cedar Rapids, Iowa, United States

Site Status

Advance Cardiovascular Specialists

Shreveport, Louisiana, United States

Site Status

Delmarva Heart Research Foundation, Inc., TidalHealth Peninsula Regional, Inc.

Salisbury, Maryland, United States

Site Status

Mass Heart and Rhythm

Leominster, Massachusetts, United States

Site Status

McLaren Bay

Bay City, Michigan, United States

Site Status

Hurley Medical Center

Flint, Michigan, United States

Site Status

Borgess Research Institute

Kalamazoo, Michigan, United States

Site Status

Great Lakes Heart And Vascular Institute

Saint Joseph, Michigan, United States

Site Status

Cardiovascular Clinic of Hattiesburg

Hattiesburg, Mississippi, United States

Site Status

Wesley Medical Center

Hattiesburg, Mississippi, United States

Site Status

Kansas City Heart Foundation

Kansas City, Missouri, United States

Site Status

PCRMC Medical Group

Rolla, Missouri, United States

Site Status

Gateway Cardiology

St Louis, Missouri, United States

Site Status

St. Louis Heart and Vascular

St Louis, Missouri, United States

Site Status

University Hospital, Newark

Newark, New Jersey, United States

Site Status

Stony Brook Community Medical, PC

East Setauket, New York, United States

Site Status

New York Hospital Queens

Flushing, New York, United States

Site Status

Westchester Heart & Vascular

Hawthorne, New York, United States

Site Status

Asheville Cardiology Associates

Asheville, North Carolina, United States

Site Status

St. Alexius Medical Center

Bismarck, North Dakota, United States

Site Status

Stark Medical Specialties

Massillon, Ohio, United States

Site Status

Integris Baptist Medical Center

Oklahoma City, Oklahoma, United States

Site Status

Oregon Cardiology Sacred Heart at Riverbend Hospital

Springfield, Oregon, United States

Site Status

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

Site Status

Heart and Vascular Institute, University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Site Status

Carolina Cardiology Assoc, Piedmont Medical Center

Rock Hill, South Carolina, United States

Site Status

Parkridge Medical Ctr.

Chattanooga, Tennessee, United States

Site Status

Sarah Cannon Research Institute

Nashville, Tennessee, United States

Site Status

Texas Heart Rhythm

Houston, Texas, United States

Site Status

Cardiology Clinic San Antonio

San Antonio, Texas, United States

Site Status

Central Utah Clinic

Provo, Utah, United States

Site Status

Cardiology Associates of Fredericksburg

Fredericksburg, Virginia, United States

Site Status

Carient Heart & Vasculare

Manassas, Virginia, United States

Site Status

CAMC Health Education and Research Institute

Charleston, West Virginia, United States

Site Status

Prevea Clinic, Inc.

Green Bay, Wisconsin, United States

Site Status

Clinical Research Specialist, Research Institute ProHealth Care, Inc

Waukesha, Wisconsin, United States

Site Status

Cardiology Research Group Royal Alexandra Hospital

Edmonton, Alberta, Canada

Site Status

Royal Columbian Hospital

New Westminster, British Columbia, Canada

Site Status

Hospital du Sacre-Coeur de Montreal

Montreal, Quebec, Canada

Site Status

Centre Hospitalier Universitaire de Sherbrooke, CHUS/CRC

Sherbrooke, Quebec, Canada

Site Status

Charite Campus Virchow Klinikum

Berlin, , Germany

Site Status

Universitätsklinikum Schleswig-Holstein, Klinik für Kardiologie und Angiologie

Kiel, , Germany

Site Status

Chiba University Hospital

Chiba, , Japan

Site Status

Fukuoka University Hospital

Fukuoka, , Japan

Site Status

University of Tsukuba Hospital

Ibaraki, , Japan

Site Status

Japan Labour Health and and Welfare Organization, Yokohama Rosai Hospital

Kanagawa-Prefecture, , Japan

Site Status

Saitama Medical University, Saitama Redcross Hospital

Saitama, , Japan

Site Status

Tokohu University Hospital

Sendai, , Japan

Site Status

Showa University Hospital

Tokyo, , Japan

Site Status

Keimyung University Dongsan Medical Center

Daegu, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Yonsei University Health System

Seoul, , South Korea

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Seoul St. Mary Hospital

Seoul, , South Korea

Site Status

Sejong General Hospital

Seoul, , South Korea

Site Status

Seoul National University Bundang Hospital

Seoul, , South Korea

Site Status

Hospital Universitario de Cruces. Servicio de Cardiología

Barakaldo, , Spain

Site Status

Hospital Universitario La Paz. Servicio de Cardiología. Sección de Arritmias. Planta primera diagonal

Madrid, , Spain

Site Status

Hospital Universitario "Miguel Servet". Servicio de Cardiología

Zaragoza, , Spain

Site Status

Universitatsspital Basel Klinik fur Kardiologie

Basel, , Switzerland

Site Status

Kantonspital St Gallen, Klinik fur Kardiologie

Sankt Gallen, , Switzerland

Site Status

Bristol Heart Institute

Bristol, , United Kingdom

Site Status

St Bartholomew's Hospital, EP Cardiac Research Department, Barts Health NHS Trust

London, , United Kingdom

Site Status

James Cook University Hospital

Middlesbrough, , United Kingdom

Site Status

University Hospital of Southhampton

Southampton, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada Germany Japan South Korea Spain Switzerland United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PDM 90912475

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improve Sudden Cardiac Arrest Study
NCT02099721 COMPLETED NA
S-ICD® System IDE Clinical Study
NCT01064076 COMPLETED NA